Skip to main content

Table 2 Examination and laboratory findings

From: Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study

Variable

Total (n = 199), mean ± SD

Group 1 (n = 135), mean ± SD

Group 2 (n = 64), mean ± SD

p value

BMI, Kg/m2

31.4 ± 6.8

32.1 ± 7.3

29.9 ± 5.2

0.015

 Obesity, no. (%)

95 (47.7)

69 (51.1)

26 (40.6)

0.167

Office SBP, mmHg

129.0 ± 7.4

128.7 ± 7.8

129.6 ± 6.6

0.421

Office DBP, mmHg

80.1 ± 5.2

80.3 ± 5.4

79.4 ± 4.9

0.261

Standing SBP, mmHg

131.2 ± 9.0

130.8 ± 9.3

132.1 ± 8.4

0.342

Standing DBP, mmHg

83.9 ± 7.4

83.3 ± 8.1

85.2 ± 5.7

0.055

Heart rate (supine), bpm

78.9 ± 8.6

79.1 ± 8.7

78.5 ± 8.3

0.651

Heart rate (standing), bpm

83.5 ± 9.4

84.0 ± 9.2

82.3 ± 10.0

0.240

Serum creatinine, mg/dL

1.1 ± 0.9

1.1 ± 1.0

1.1 ± 0.4

0.862

Fasting blood glucose, mg/dL

102.9 ± 28.2

101.7 ± 32.0

105.3 ± 18.1

0.415

Serum cholesterol, mg/dL

173.9 ± 31.5

176.1 ± 34.4

169.4 ± 24.1

0.179

Serum LDL, mg/dL

114.8 ± 25.2

116.6 ± 26.8

111.2 ± 21.6

0.183

Serum HDL, mg/dL

46.5 ± 8.0

47.6 ± 7.7

44.5 ± 8.3

0.014

Serum TG, mg/dL

157.0 ± 35.0

156.5 ± 38.6

158.1 ± 28.1

0.768

Serum uric acid, mg/dL

5.9 ± 1.4

5.9 ± 1.4

5.9 ± 1.5

0.940

Serum K, mEq/L

4.2 ± 0.4

4.2 ± 0.4

4.2 ± 0.4

0.953

Serum Hb, g/L

13.3 ± 1.1

13.3 ± 1.2

13.2 ± 1.0

0.665